Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure.

Journal of medical virology - 1 Jul 2002

Servais Jean, Plesséria Jean-Marc, Lambert Christine, Fontaine Elodie, Robert Isabelle, Arendt Vic, Staub Thérèse, Schneider François, Hemmer Robert, Schmit Jean-Claude

Abstract excerpt

An "in-house" recombinant virus protease inhibitor susceptibility assay was carried out (median of 3 per patient) retrospectively in 26 patients failing HIV protease inhibitor based therapy at regular intervals to the initiation of the first protease inhibitor. Patients were treated with either indinavir (N = 6), ritonavir (N = 10), or saquinavir (N = 10) and two nucleoside analogues. Second line therapy was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Longitudinal Studies

Share to Predictive Value of Tests

Share to Treatment Failure

Source

Identifiers

PMID: 12116020
DOI: 10.1002/jmv.10076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure.PMID 12116020Read ↗

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies.Semantic proximity Read ↗

Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutations.Semantic proximity Read ↗

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.Semantic proximity Read ↗

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.Semantic proximity Read ↗

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor.Semantic proximity Read ↗

Cross-resistance patterns among HIV protease inhibitors.Semantic proximity Read ↗

Constrained evolution of human immunodeficiency virus type 1 protease during sequential therapy with two distinct protease inhibitors.Semantic proximity Read ↗

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Resistance to protease inhibitors.Semantic proximity Read ↗

Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538).Semantic proximity Read ↗

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.Semantic proximity Read ↗

Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.